Lonza to double production of Covid-19 vaccine at Swiss plant
Lonza has struggled to recruit enough workers to join its Visp plant, which now has three production lines set up and plans three more by early 2022.
Keystone / Olivier Maire
Swiss biotech firm Lonza will add three more production lines to its site in Visp, southwestern Switzerland, to manufacture an active ingredient for the Moderna vaccine, as part of a larger effort to boost the global supply of doses.
This content was published on
2 minutes
swissinfo.ch/SRF/gw
Español
es
Lonza duplicará la producción de la vacuna COVID-19 en su planta suiza
The new production lines will be added gradually to three existing lines and be fully operational by early 2022, Lonza said on Thursday. The two companies signed a ten-year contract in 2020 that enables Lonza to make a drug substance for the mRNA vaccine at its plant for the global market outside the United States.
In a separate press release, Moderna said it planned to increase the overall supply to up to three billion doses by 2022. The firm calculates there will be greater demand for its vaccine as the need for booster shots is likely to grow starting next year.
The announcement comes as Lonza struggles to recruit enough workers to join its Visp plant. Biotech specialists are currently in high demand worldwide as a result of the pandemic, Swiss public television, SRF, reported, adding that the interior ministry is now actively helping Lonza to find specialists from inside the federal administration and universities, including the federal technology institutes ETH Zurich and the EPFL in Lausanne.
Lonza has reportedly recruited temporary staff from food giant Nestlé with help from the Swiss government. Moderna has blamed projected delays in shipments of the vaccine to markets such as the UK and Canada on production bottlenecks, according to Reuters.
Related Stories
Popular Stories
More
Global elections
One Swiss man’s patient work towards a democratic Romania
Swiss foreign minister praises improved relations with Italy
This content was published on
Swiss Foreign Minister Ignazio Cassis expressed his satisfaction on Tuesday with the good relations that Switzerland has developed with Italy.
Boating and swimming to be banned on part of River Aare in Bern
This content was published on
From September, the city and canton of Bern will be carrying out extensive construction work on the River Aare to protect against flooding and to renovate the Marzili outdoor pool.
Moutier: foreigners familiarise themselves with right to vote
This content was published on
From 2026, Moutier will be part of the Swiss canton of Jura, gaining more than 1,000 new voters. On Monday around 50 people were informed about their new rights.
Switzerland ‘more than ready’ to host Ukraine summit
This content was published on
Switzerland is more than ready to host a summit between Russia and Ukraine, says Swiss Foreign Minister Ignazio Cassis, highlighting Switzerland's expertise in this area.
This content was published on
Every second aircraft at Zurich Airport took off late this summer. However, the situation has already improved significantly compared to last year.
Swiss union federation demands average wage increase of 2%
This content was published on
The employees' umbrella organisation Travailsuisse is demanding an average wage increase of two percent for all employees in the coming year. This would cover the rising cost of living and make up for wage shortfalls in recent years.
‘Dr Pump’ sentenced for administering unauthorised substances
This content was published on
A Bern Regional Court has found the Solothurn doctor known as "Dr Pump" guilty of offences against the Sports Promotion Law. The man had administered unauthorised substances to patients.
This content was published on
Volunteering can have a positive effect on mental health. According to a survey conducted in Switzerland, Germany and Austria, people who volunteer for others also strengthen themselves.
Swiss firm Lonza to help produce anti-Covid nasal spray in the US
This content was published on
As part of its agreement with American company Altimmune, Lonza will allocate a dedicated manufacturing facility for AdCOVID nasal spray vaccine.
Switzerland mulls future European coordination on medical supplies
This content was published on
“The pandemic has shown us that we are very dependent, maybe too much so, on other markets,” Swiss President Guy Parmelin has said.
Switzerland in race for sufficient Covid immunisation
This content was published on
Health authorities have called for an extra effort from the Swiss population to keep Covid infections as low as possible in the next few months.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.